Books
Explore the evidence behind our pharma-specific pricing, forecasting, and conjoint approaches
Value-Based Pricing for Pharmaceuticals, Second edition
New in this second edition: Where AI can and cannot help in pricing. Understanding the “AI Cube” framework to predict where AI will work best. How ChatGPT “trains itself” and…
Download Sample Chapter
Pharma-Specific Conjoint, Second edition
Pharma-Specific Conjoint: Evidence-Based Conjoint for and Evidence-Based Industry Second Edition By Gary Johnson and Sam Johnson What's new in this second edition: Where AI can and cannot help with conjoint.…
Download Sample Chapter
The AI Cube
The AI Cube: Can We Use AI in Pharma Pricing and Forecasting? By Gary Johnson and Sam Johnson List of contents: Introduction: The AI Cube Chapter 1: A background on…
Download Sample Chapter
Sales Forecasting for Pharmaceuticals
Sales Forecasting for Pharmaceuticals: An Evidence-Based Approach By Gary Johnson List of contents: Introduction: The problem with forecasting Chapter 1: The six principles of good forecasting Chapter 2: Informal forecasts…
Download Sample Chapter
Value Pricing for Market Access
Value Pricing for Market Access: Evidence-based pricing for pharmaceuticals By Gary Johnson List of contents: Introduction: Pricing is the moment of truth Chapter 1: Why “talking to payers” is not…
Download Sample Chapter
Book
Download this sample chapter
Related case studies
Our client didn’t know what they needed to know from payers. AI to the rescue
Read Case StudyHow our client got forecast-ready market shares without conducting primary research
Read Case StudyHow our client got reliable price and value driver insights from payers in a rare neurology indication
Read Case StudyWe tailor our services to your exact requirements
Get in touch with us and arrange a meeting